{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T01:15:18Z","timestamp":1783559718678,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Medical science research project of hebei","award":["20250589"],"award-info":[{"award-number":["20250589"]}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"crossref","award":["H2024206055"],"award-info":[{"award-number":["H2024206055"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Central Government-Guided Local Science and Technology Development Fund","award":["246Z7702G"],"award-info":[{"award-number":["246Z7702G"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Diabetes mellitus significantly impacts perioperative anesthetic management. Patients with diabetic neuropathy exhibit increased sensitivity to local anesthetics, yet the underlying mechanisms, particularly regarding the median effective dose (ED\n                    <jats:sub>50<\/jats:sub>\n                    ) of ropivacaine and the role of voltage-gated sodium channels (Navs), remain incompletely elucidated. This study investigated the role of Navs in mediating the ED\n                    <jats:sub>50<\/jats:sub>\n                    of ropivacaine in streptozotocin (STZ)-induced diabetic rats. Using the Dixon up-and-down method, the ED\n                    <jats:sub>50<\/jats:sub>\n                    for sciatic nerve motor block was significantly lower in diabetic rats (0.100%) than in controls (0.142%), indicating heightened local anesthetic sensitivity. This pharmacodynamic shift was associated with underlying neuropathic changes, including reduced motor nerve conduction velocity (MNCV), decreased axon density, and downregulated expression of key Nav subtypes (Nav1.7, Nav1.8, Nav1.9) and the contactin-associated protein (CASPR) in the sciatic nerve and dorsal root ganglia (DRG). Crucially, administration of ropivacaine at the identified ED\n                    <jats:sub>50<\/jats:sub>\n                    dose did not exacerbate neurophysiological dysfunction, histological damage, or alter Navs\/CASPR expression in diabetic nerves compared with saline-treated diabetic group, demonstrating a favorable safety profile. These findings elucidate the mechanism underlying reduced local anesthetic requirements in diabetic neuropathy, which involves Navs downregulation and structural nerve alterations, and support the clinical use of lower, effective ropivacaine doses in diabetic patients to achieve successful analgesia without increasing neurotoxicity risk.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-49845-w","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T09:17:10Z","timestamp":1778318230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of voltage-gated sodium channels on the median effective dose of ropivacaine in diabetic rats"],"prefix":"10.1038","volume":"16","author":[{"given":"Xueyin","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaozong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoya","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlei","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiujun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"49845_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m997","volume":"369","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: National cross sectional study. BMJ 369, m997 (2020).","journal-title":"BMJ"},{"key":"49845_CR2","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi, P. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 157, 107843 (2019).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"49845_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.7196\/SAMJ.2019.v109i10.013898","volume":"109","author":"T Biesman-Simons","year":"2019","unstructured":"Biesman-Simons, T. et al. A multicentre prospective observational study of the prevalence and glycaemic control of diabetes mellitus in adult non-cardiac elective surgical patients in hospitals in Western Cape Province, South Africa. S. Afr. Med. J. 109, 801\u2013806 (2019).","journal-title":"S. Afr. Med. J."},{"key":"49845_CR4","doi-asserted-by":"publisher","first-page":"ii26","DOI":"10.1093\/bja\/aev377","volume":"115","author":"PM Hopkins","year":"2015","unstructured":"Hopkins, P. M. Does regional anaesthesia improve outcome?. Br. J. Anaesth. 115, ii26-33 (2015).","journal-title":"Br. J. Anaesth."},{"key":"49845_CR5","doi-asserted-by":"publisher","first-page":"i90","DOI":"10.1093\/bja\/aer340","volume":"107","author":"SC Kettner","year":"2011","unstructured":"Kettner, S. C., Willschke, H. & Marhofer, P. Does regional anaesthesia really improve outcome?. Br. J. Anaesth. 107, i90\u2013i95 (2011).","journal-title":"Br. J. Anaesth."},{"key":"49845_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/bja\/66.1.31","volume":"66","author":"MS Brockway","year":"1991","unstructured":"Brockway, M. S., Bannister, J., McClure, J. H., McKeown, D. & Wildsmith, J. A. Comparison of extradural ropivacaine and bupivacaine. Br. J. Anaesth. 66, 31\u201337 (1991).","journal-title":"Br. J. Anaesth."},{"key":"49845_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/anae.15258","volume":"76","author":"N Levy","year":"2021","unstructured":"Levy, N. & Lirk, P. Regional anaesthesia in patients with diabetes. Anaesthesia 76, 127\u2013135 (2021).","journal-title":"Anaesthesia"},{"key":"49845_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1055\/a-1946-3813","volume":"131","author":"D Ziegler","year":"2023","unstructured":"Ziegler, D., Keller, J., Maier, C. & Pannek, J. Diabetic neuropathy. Exp. Clin. Endocrinol. Diabetes 131, 72\u201383 (2023).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"49845_CR9","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/bja\/aew027","volume":"116","author":"S Heschl","year":"2016","unstructured":"Heschl, S. et al. Diabetic neuropathy increases stimulation threshold during popliteal sciatic nerve block. Br. J. Anaesth. 116, 538\u2013545 (2016).","journal-title":"Br. J. Anaesth."},{"key":"49845_CR10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/ALN.0000000000002035","volume":"128","author":"W Ten Hoope","year":"2018","unstructured":"Ten Hoope, W. et al. Pharmacodynamics and pharmacokinetics of lidocaine in a rodent model of diabetic neuropathy. Anesthesiology 128, 609\u2013619 (2018).","journal-title":"Anesthesiology"},{"key":"49845_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12917-020-02459-4","volume":"16","author":"L Markova","year":"2020","unstructured":"Markova, L. et al. Neurotoxicity of bupivacaine and liposome bupivacaine after sciatic nerve block in healthy and streptozotocin-induced diabetic mice. BMC Vet. Res. 16, 247 (2020).","journal-title":"BMC Vet. Res."},{"key":"49845_CR12","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1111\/anae.14347","volume":"73","author":"M Baeriswyl","year":"2018","unstructured":"Baeriswyl, M. et al. Comparison of peripheral nerve blockade characteristics between non-diabetic patients and patients suffering from diabetic neuropathy: A prospective cohort study. Anaesthesia 73, 1110\u20131117 (2018).","journal-title":"Anaesthesia"},{"key":"49845_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41583-021-00444-w","volume":"22","author":"G Goodwin","year":"2021","unstructured":"Goodwin, G. & McMahon, S. B. The physiological function of different voltage-gated sodium channels in pain. Nat. Rev. Neurosci. 22, 263\u2013274 (2021).","journal-title":"Nat. Rev. Neurosci."},{"key":"49845_CR14","doi-asserted-by":"publisher","first-page":"29341","DOI":"10.1074\/jbc.M404167200","volume":"279","author":"S Hong","year":"2004","unstructured":"Hong, S., Morrow, T. J., Paulson, P. E., Isom, L. L. & Wiley, J. W. Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. J. Biol. Chem. 279, 29341\u201329350 (2004).","journal-title":"J. Biol. Chem."},{"key":"49845_CR15","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.bbrc.2005.11.057","volume":"339","author":"S Hong","year":"2006","unstructured":"Hong, S. & Wiley, J. W. Altered expression and function of sodium channels in large DRG neurons and myelinated A-fibers in early diabetic neuropathy in the rat. Biochem. Biophys. Res. Commun. 339, 652\u2013660 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"49845_CR16","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/bja\/aes496","volume":"110","author":"P Cuvillon","year":"2013","unstructured":"Cuvillon, P. et al. Comparison of subgluteal sciatic nerve block duration in type 2 diabetic and non-diabetic patients. Br. J. Anaesth. 110, 823\u2013830 (2013).","journal-title":"Br. J. Anaesth."},{"key":"49845_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1591581","volume":"12","author":"A Wang","year":"2025","unstructured":"Wang, A. et al. Impact of temperature on EC50 of ropivacaine in axillary brachial plexus blocks: Based on Dixon\u2019s up-and-down method. Front. Med. 12, 1591581 (2025).","journal-title":"Front. Med."},{"key":"49845_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bja.2018.08.022","volume":"122","author":"ZY Yu","year":"2019","unstructured":"Yu, Z. Y. et al. Dexmedetomidine enhances ropivacaine-induced sciatic nerve injury in diabetic rats. Br. J. Anaesth. 122, 141\u2013149 (2019).","journal-title":"Br. J. Anaesth."},{"key":"49845_CR19","doi-asserted-by":"publisher","first-page":"BSR20190817","DOI":"10.1042\/BSR20190817","volume":"39","author":"N Zhang","year":"2019","unstructured":"Zhang, N. et al. Effect of ropivacaine on peripheral neuropathy in streptozocin diabetes-induced rats through TRPV1-CGRP pathway. Biosci. Rep. 39, BSR20190817 (2019).","journal-title":"Biosci. Rep."},{"key":"49845_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2011.00068","volume":"2","author":"HA Fozzard","year":"2011","unstructured":"Fozzard, H. A., Sheets, M. F. & Hanck, D. A. The sodium channel as a target for local anesthetic drugs. Front. Pharmacol. 2, 68 (2011).","journal-title":"Front. Pharmacol."},{"key":"49845_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-070918-050144","volume":"42","author":"SD Dib-Hajj","year":"2019","unstructured":"Dib-Hajj, S. D. & Waxman, S. G. Sodium channels in human pain disorders: Genetics and pharmacogenomics. Annu. Rev. Neurosci. 42, 87\u2013106 (2019).","journal-title":"Annu. Rev. Neurosci."},{"key":"49845_CR22","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-immunol-041015-055340","volume":"34","author":"S Talbot","year":"2016","unstructured":"Talbot, S., Foster, S. L. & Woolf, C. J. Neuroimmunity: Physiology and pathology. Annu. Rev. Immunol. 34, 421\u2013447 (2016).","journal-title":"Annu. Rev. Immunol."},{"key":"49845_CR23","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.4103\/1673-5374.215268","volume":"12","author":"Y Zou","year":"2017","unstructured":"Zou, Y. et al. Structure and function of the contactin-associated protein family in myelinated axons and their relationship with nerve diseases. Neural Regen. Res. 12, 1551\u20131558 (2017).","journal-title":"Neural Regen. Res."},{"key":"49845_CR24","doi-asserted-by":"publisher","first-page":"7387","DOI":"10.1523\/JNEUROSCI.0322-04.2004","volume":"24","author":"BS Shah","year":"2004","unstructured":"Shah, B. S. et al. Contactin associates with sodium channel Nav1.3 in native tissues and increases channel density at the cell surface. J. Neurosci. 24, 7387\u20137399 (2004).","journal-title":"J. Neurosci."},{"key":"49845_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4103\/1673-5374.244776","volume":"14","author":"M Chatterjee","year":"2019","unstructured":"Chatterjee, M., Schild, D. & Teunissen, C. E. Contactins in the central nervous system: Role in health and disease. Neural Regen. Res. 14, 206\u2013216 (2019).","journal-title":"Neural Regen. Res."},{"key":"49845_CR26","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1097\/j.pain.0000000000001807","volume":"161","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. Pharmacological characterization of a rat Nav1.7 loss-of-function model with insensitivity to pain. Pain 161, 1350\u20131360 (2020).","journal-title":"Pain"},{"key":"49845_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.135844","volume":"753","author":"Y Xue","year":"2021","unstructured":"Xue, Y., Chidiac, C., Herault, Y. & Gaveriaux-Ruff, C. Pain behavior in SCN9A (Nav1.7) and SCN10A (Nav1.8) mutant rodent models. Neurosci. Lett. 753, 135844 (2021).","journal-title":"Neurosci. Lett."},{"key":"49845_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117557","volume":"250","author":"SE Elkholy","year":"2020","unstructured":"Elkholy, S. E., Elaidy, S. M., El-Sherbeeny, N. A., Toraih, E. A. & El-Gawly, H. W. Neuroprotective effects of ranolazine versus pioglitazone in experimental diabetic neuropathy: Targeting Nav1.7 channels and PPAR-\u03b3. Life Sci. 250, 117557 (2020).","journal-title":"Life Sci."},{"key":"49845_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17091479","volume":"17","author":"L Yang","year":"2016","unstructured":"Yang, L., Li, Q., Liu, X. & Liu, S. Roles of voltage-gated tetrodotoxin-sensitive sodium channels NaV1.3 and NaV1.7 in diabetes and painful diabetic neuropathy. Int. J. Mol. Sci. 17, 1479 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"49845_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00221-011-2994-3","volume":"217","author":"KE Power","year":"2012","unstructured":"Power, K. E., Carlin, K. P. & Fedirchuk, B. Modulation of voltage-gated sodium channels hyperpolarizes the voltage threshold for activation in spinal motoneurones. Exp. Brain Res. 217, 311\u2013322 (2012).","journal-title":"Exp. Brain Res."},{"key":"49845_CR31","doi-asserted-by":"publisher","first-page":"8958","DOI":"10.1038\/s41598-017-09405-9","volume":"7","author":"JY Lee","year":"2017","unstructured":"Lee, J. Y. et al. Nogo receptor 1 regulates Caspr distribution at axo-glial units in the central nervous system. Sci. Rep. 7, 8958 (2017).","journal-title":"Sci. Rep."},{"key":"49845_CR32","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1093\/brain\/awg151","volume":"126","author":"G Wolswijk","year":"2003","unstructured":"Wolswijk, G. & Balesar, R. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis. Brain 126, 1638\u20131649 (2003).","journal-title":"Brain"},{"key":"49845_CR33","doi-asserted-by":"publisher","first-page":"14820","DOI":"10.1523\/JNEUROSCI.3369-14.2014","volume":"34","author":"A Gordon","year":"2014","unstructured":"Gordon, A. et al. Caspr and Caspr2 are required for both radial and longitudinal organization of myelinated axons. J. Neurosci. 34, 14820\u201314826 (2014).","journal-title":"J. Neurosci."},{"key":"49845_CR34","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/rapm-2024-105950","volume":"50","author":"JA Wildsmith","year":"2025","unstructured":"Wildsmith, J. A. Axonal sensitivity and block dynamics. Reg. Anesth. Pain Med. 50, 280\u2013282 (2025).","journal-title":"Reg. Anesth. Pain Med."},{"key":"49845_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14040353","volume":"14","author":"NE Kim","year":"2024","unstructured":"Kim, N. E. et al. Diabetic neuropathy and minimum effective anesthetic concentration of Mepivacaine for axillary brachial plexus block: A prospective observational study. J. Pers. Med. 14, 353 (2024).","journal-title":"J. Pers. Med."},{"key":"49845_CR36","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1097\/j.pain.0000000000002765","volume":"164","author":"P Baskaran","year":"2023","unstructured":"Baskaran, P. et al. Evaluation of a polymer-coated nanoparticle cream formulation of resiniferatoxin for the treatment of painful diabetic peripheral neuropathy. Pain 164, 782\u2013790 (2023).","journal-title":"Pain"},{"key":"49845_CR37","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1097\/ALN.0b013e318221fcc9","volume":"115","author":"CM Brummett","year":"2011","unstructured":"Brummett, C. M., Hong, E. K., Janda, A. M., Amodeo, F. S. & Lydic, R. Perineural dexmedetomidine added to ropivacaine for sciatic nerve block in rats prolongs the duration of analgesia by blocking the hyperpolarization-activated cation current. Anesthesiology 115, 836\u2013843 (2011).","journal-title":"Anesthesiology"},{"key":"49845_CR38","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/AAP.0000000000000745","volume":"43","author":"BS Kim","year":"2018","unstructured":"Kim, B. S., Choi, J. H., Baek, S. H. & Lee, D. H. Effects of intraneural injection of dexmedetomidine in combination with ropivacaine in rat sciatic nerve block. Reg. Anesth. Pain Med. 43, 378\u2013384 (2018).","journal-title":"Reg. Anesth. Pain Med."},{"key":"49845_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/bja\/aeu270","volume":"114","author":"P Lirk","year":"2015","unstructured":"Lirk, P. et al. Effects of early and late diabetic neuropathy on sciatic nerve block duration and neurotoxicity in Zucker diabetic fatty rats. Br. J. Anaesth. 114, 319\u2013326 (2015).","journal-title":"Br. J. Anaesth."},{"key":"49845_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0149-7634(05)80090-9","volume":"15","author":"WJ Dixon","year":"1991","unstructured":"Dixon, W. J. Staircase bioassay: The up-and-down method. Neurosci. Biobehav. Rev. 15, 47\u201350 (1991).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"49845_CR41","volume":"140","author":"YT Lin","year":"2018","unstructured":"Lin, Y. T. & Chen, J. C. Dorsal root ganglia isolation and primary culture to study neurotransmitter release. J. Vis. Exp. 140, 57569 (2018).","journal-title":"J. Vis. Exp."},{"key":"49845_CR42","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/01.anes.0000267514.42592.2a","volume":"107","author":"NL Pace","year":"2007","unstructured":"Pace, N. L. & Stylianou, M. P. Advances in and limitations of up-and-down methodology: A pr\u00e9cis of clinical use, study design, and dose estimation in anesthesia research. Anesthesiology 107, 144\u2013152 (2007).","journal-title":"Anesthesiology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49845-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49845-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49845-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T01:03:32Z","timestamp":1783559012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49845-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49845"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49845-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21305"}}